The Methamphetamine Epidemic

Methamphetamine became one of the most widespread and damaging drug crises of its time. What began decades earlier in smaller, localized groups eventually expanded into a national problem, affecting individuals, families, and entire communities. Its rapid spread was driven not only by demand, but by how accessible key ingredients commonly found in cold medications (e.g., ephedrine and pseudoephedrine) were for illegal production.

This FRONTLINE documentary examines how methamphetamine use spiraled during that period, tracing its rise from early distribution networks to large-scale trafficking and domestic lab production. It also explores the tension between regulating these chemical ingredients and maintaining access to legitimate medicine, highlighting how gaps in control allowed the problem to grow. Through this, the film captures a critical moment in the evolution of the meth epidemic and the challenges faced in trying to contain it.

"Methamphetamine, unlike most other hard drugs out there, is uniquely susceptible to supply side intervention because it's not something you can grow. It's not something you get out of poppy fields or out of coca plants. It's something you gotta cook up in a factory, you gotta make this stuff."⁴

"While the U.S. government was spending billions trying to control heroin and cocaine, meth was such a low priority that no one was bothering to monitor who was shopping at the nine factories that make the key ingredients in meth."⁵

"During one 18-month period in the early 1990s, the Amezcua brothers purchased 170 tons of ephedrine from the nine factories and shipped it into the United States, where it was turned into two billion hits of meth. The meth on America's streets was suddenly cheap, plentiful, and most important, remarkably pure. And soon the addiction rate skyrocketed, creating the first great spike of American meth abuse."⁶

"When the purity of the meth on the street falls, not only do fewer first-time users become addicted, but those who are addicted find it easier to get clean. And that gives places like On Track and its director, Rita Sullivan, a chance."⁷

¹ The Combat Methamphetamine Epidemic Act of 2005 restricted access to pseudoephedrine by requiring it to be sold behind pharmacy counters and limiting purchase quantities, significantly reducing small-scale domestic meth labs. However, these controls had only a temporary impact on overall meth use, as production shifted to alternative methods and large-scale trafficking, reflecting a broader transition in the methamphetamine market.
² Although methamphetamine use has been associated with increased criminal activity, research does not support the claim that it is the leading cause of property or violent crime. Studies examining large-scale supply disruptions found no significant corresponding decrease in property or violent crime rates, suggesting that the relationship between meth use and crime is complex and not a primary driver at the population level.
³ Preclinical studies measuring dopamine levels in the brain's reward system have shown that methamphetamine can produce extremely large increases in dopamine release compared to natural rewards or other drugs. These findings are typically expressed as a percentage of baseline levels in animal models rather than precise human measurements, but they illustrate the unusually strong stimulation of the brain's reward pathways associated with meth use.
⁴ Because methamphetamine is a fully synthetic drug, its production depends on access to chemical precursors rather than agricultural cultivation, making it theoretically responsive to supply-side controls. However, restrictions on key ingredients have historically led to shifts in production methods and supply chains, including the rise of alternative synthesis processes and large-scale manufacturing, limiting the long-term effectiveness of these interventions.
⁵ In the 1990s, the United States saw a rapid rise in methamphetamine production, driven by a significant regulatory loophole that allowed illicit, large-scale manufacturers to buy massive quantities of ephedrine and pseudoephedrine. While federal law tried to restrict bulk chemicals, it failed to monitor "single-entity" tablets (pills containing only ephedrine), enabling traffickers to create "super labs".
⁶ Between 1993 and 1994, the DEA discovered that the Amezcua brothers smuggled approximately 170 tons of ephedrine into the United States over an 18-month period. This volume was estimated to be enough to produce 2 billion hits of methamphetamine.
⁷ Rita Sullivan was fired following an investigation. The suit alleged that Jeremy Braun intimidated and coerced his patient to have sex with him during a drug counselling session and that Rita Sullivan, as OnTrack's founder and director, knew about this sexual abuse and prior incidents of sexual abuse of OnTrack clients by Jeremy Braun.